The National Times - European stocks rise tracking earnings, US jobs

European stocks rise tracking earnings, US jobs


European stocks rise tracking earnings, US jobs

European stock markets rose Thursday as traders digested a string of company earnings and a stronger-than-expected US jobs report, which boosted optimism about the health of the world's largest economy.

Change text size:

Asian markets were subdued after a weak close Wednesday on Wall Street, as investors pared back bets on Federal Reserve interest rate cuts and the share prices of tech firms again underperformed.

"The strength seen in Europe... comes from improved earnings data from some of the big hitters," said Joshua Mahony, chief market analyst at Scope Markets.

Shares in German industrial giant Siemens jumped seven percent as it raised its outlook for the year after a strong first quarter boosted by spending on artificial intelligence.

In Paris, RayBan maker EssilorLuxottica shares rose around four percent as its fourth-quarter earnings beat market expectations.

London edged up to a fresh record high, even as data showed the UK economy grew less than expected in the final three months of 2025.

British asset manager Schroders was the biggest riser in the FTSE 100 index after agreeing a takeover by the US firm Nuveen, sending its shares up 28 percent to reflect the premium paid for the company.

Investors were also reacting to a bumper US jobs report on Wednesday that eased concerns about the state of the world's top economy, even though it reduced expectations for Federal Reserve interest rate cuts to spur growth.

Around 130,000 US jobs were created last month, more than double what was forecast, while unemployment unexpectedly dipped.

The reading soothed concerns about the economy that had been stoked by a report earlier this week showing weak US consumer activity.

"This was a solid report across headline job creation, unemployment, and wage growth, easing concerns over the health of the US labour market," wrote Fiona Cincotta, senior market analyst at City Index.

However, "The markets have pushed back on expectations for the next rate cut by the Federal Reserve to July, compared to June previously," she added.

The winners in Asia on Thursday were again led by Seoul's Kospi index, the world's best performer this year thanks to a surge in chipmakers Samsung and SK hynix as traders turn to the region's AI plays.

The region's recent rally comes amid a turn from Wall Street titans caused by concerns about extended valuations of firms such as Microsoft and Meta amid massive investments in AI deployment.

Shanghai closed higher, while Hong Kong retreated and Tokyo was flat.

The dollar weakened against the yen despite waning expectations for an early US rate cut and the prospect of big Japanese spending after Prime Minister Sanae Takaichi's landslide election win.

Analysts said the yen's advance has been helped by the sense of stability in Tokyo caused by the governing party's big win.

The dollar was also down against the pound and euro.

- Key figures at around 1120 GMT -

London - FTSE 100: UP 0.2 percent at 10,495.18 points

Paris - CAC 40: UP 0.7 percent at 8,372.71

Frankfurt - DAX: UP 1.4 percent at 25,206.64

Tokyo - Nikkei 225: FLAT at 57,639.84 (close)

Hong Kong - Hang Seng Index: DOWN 0.9 percent at 27,032.54 (close)

Shanghai - Composite: UP 0.1 percent at 4,134.02 (close)

New York - Dow: DOWN 0.1 percent at 50,121.40 (close)

Euro/dollar: UP at $1.1882 from $1.1874 on Wednesday

Pound/dollar: UP at $1.3645 from $1.3628

Dollar/yen: DOWN at 153.09 yen from 153.14 yen

Euro/pound: DOWN at 87.10 pence from 87.13 pence

Brent North Sea Crude: DOWN 0.6 percent at $69.02 per barrel

West Texas Intermediate: DOWN 0.5 percent at $64.32 per barrel

G.Waters--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: